EryA gene deleted strain of brucella Rev.1, construction method and application thereof
A brucella and gene deletion technology, applied in the field of genetic engineering, can solve the problems of inability to purify brucellosis, inability to distinguish natural infection from artificial immunity, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] Embodiment 1: the construction of the eryA gene deletion strain of Brucella Rev.1
[0047]This embodiment aims at constructing the eryA gene deletion strain of Brucella Rev.1 by genetic engineering technology, specifically comprises the following steps:
[0048] 1.1. PCR amplification to obtain the upstream and downstream homology arms of the eryA gene and the suicide gene SacB
[0049] Using the genome of Brucella melis Rev.1 strain (extracted by a genome extraction kit) as a template, use the high-fidelity enzyme (GXL) and the primers listed in Table 1 below to target the eryA gene and its upstream and downstream homologs, respectively. Arms (named eryA-1 and eryA-2, respectively) were amplified by PCR to obtain PCR amplifications of the eryA gene, the upstream homology arm of the eryA gene (eryA-1) and the downstream homology arm of the eryA gene (eryA-2). increase product. Using the plasmid pre112 as a template, the suicide gene SacB was amplified using the primer...
Embodiment 2
[0069] Embodiment 2: Physiological and biochemical characteristics and growth characteristic identification of the eryA gene deletion strain of Brucella Rev.1
[0070] This embodiment aims to identify the physiological and biochemical characteristics and growth characteristics of the eryA gene deletion strain (Rev.1-ΔeryA) of the Brucella Rev.1 constructed in the above-mentioned embodiment 1, and compare with the original Brucella Rev. 1 (Rev.1) wild strain, Brucella A19 (vaccine strain), S19 (vaccine strain, missing 720bp fragment relative to A19), S2 (vaccine strain) (preserved by Jinyu Baoling Biological Pharmaceutical Co., Ltd.) The comparison specifically includes the following steps:
[0071] 2.1 Morphology and biochemical characteristics
[0072] The eryA gene deletion strain of Brucella Rev.1 and other Brucella strains (Rev.1, A19, S19, S2) were observed by Gram staining and Kovik staining respectively, and prepared with lead acetate Use an inoculation loop to inocul...
Embodiment 3
[0082] Embodiment 3: the distinction method establishment of Brucella wild strain and Brucella Rev.1-ΔeryA vaccine strain
[0083] eryA is a conserved gene of Brucella, and the homology of the gene among the strains is as high as 99% through sequence comparison. Therefore, the deletion strain vaccine of this gene can be used to effectively distinguish the wild strain of Brucella from the vaccine strain , including the following steps:
[0084] The genomes of Brucella S2, A19, S19, M5, M28, Rev.1 (all preserved by Jinyu Baoling Biopharmaceutical Co., Ltd.) and Rev.1-ΔeryA (extracted using a genome extraction kit) were used as templates , using the eryA-F and eryA-R primers listed in Table 1 above for PCR amplification, the reaction system is: Mix 12.5μL, ddH 2 O 9.5 μL, upstream primer (eryA-F) 1 μL, downstream primer (eryA-R) 1 μL, DNA template 1 μL. The reaction conditions were: denaturation at 95°C for 3 min; denaturation at 94°C for 45 s, 35 cycles, annealing at 55°C for ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com